Valeant Pharmaceuticals Expands Bausch + Lomb Manufacturing Facility, Adding 120 New Jobs in Rochester, NYSeptember 9, 2014 8:39 am | News | Comments
Valeant Pharmaceuticals hosted a ribbon cutting ceremony for the new Bausch + Lomb ULTRA contact lens manufacturing lines and solar array assembly at the company's Optics Center in Rochester, NY. The ceremony recognized the expansion and installation of the new manufacturing lines, which will produce the company's silicone hydrogel contact lens, Bausch + Lomb ULTRA.
China has fined Johnson & Johnson, Nikon and five other foreign makers of eyeglasses and...
Valeant says the loss includes restructuring, integration and other charges of $135 million...
Valeant Pharmaceuticals is seeing more clearly the merits of its acquisition last summer of eye...
New York officials say a $5.8 million grant and up to $6.2 million in tax credits have figured into Bausch & Lomb's decision to expand manufacturing and distribution in Rochester, N.Y. Gov. Andrew Cuomo says Valeant Pharmaceutical International will invest $106 million to expand capacity for its subsidiary's new line of contact lenses.
Forest Laboratories, Inc. today announced that Brenton L. Saunders, 43, the former Chief Executive Officer of Bausch + Lomb, has been appointed Forest's Chief Executive Officer and President, effective October 1, 2013. Mr. Saunders, who will succeed Howard Solomon, has served as a Forest director since August 2011.
Valeant said Monday that it will eliminate as much as 15 percent of its workforce and move Bausch & Lomb's headquarters to New Jersey as part of its $8.7 billion acquisition of the company.In a letter to its own and Bausch & Lomb workers, Valeant said that after the deal closes, it will eliminate between 10 percent and 15 percent of positions companywide. That works out to between 1,850 and 2,775 people.
Canadian drugmaker Valeant Pharmaceuticals says it will buy eye-health company Bausch + Lomb for $8.7 billion in cash in a massive expansion of its ophthalmology business. Valeant says the deal will help it capitalize on increasing demand for contact lenses and other products because of aging...
Bausch + Lomb and Lions Clubs International Foundation (LCIF) awarded the Tianjin Eye Hospital a grant to finance a specialized pediatric cataract training initiative. The grant is made possible through the Pediatric Cataract Initiative (PCI).
Bausch + Lomb announced today that it has completed its acquisition of ISTA Pharmaceuticals, Inc. The addition of ISTA bolsters Bausch + Lomb's product portfolio and pipeline, increasing the company's therapeutic offerings for physicians and their patients and creating opportunity for future growth.
Bausch + Lomb has announced plans to launch a pharmaceutical business in India through a strategic agreement with Micro Labs, a leading provider of quality healthcare products.
Bausch + Lomb is one of the best-known and most respected healthcare companies in the world. Its core businesses include contact lenses and lens care products, ophthalmic surgical devices and instruments, and ophthalmic pharmaceuticals. Founded in 1853, the company is headquartered in Rocheste
Hi-Tech Pharmacal has acquired the rights to the Abbreviated New Drug Application (ANDA) for Nystatin Oral suspension from Bausch + Lomb, the global eye health company for an undisclosed upfront payment and a future royalty.
Bausch + Lomb has announced the appointment of Calvin W. Roberts, M.D. to the newly created position of Chief Medical Officer (CMO). Dr. Roberts will serve as a member of the Executive Leadership Team and coordinate the company's global D&R efforts across the Vision Care, Pharmaceuticals and Surgical business units for greater leverage and outcomes.
Bausch + Lomb, the global eye health company, today announced the appointment of Calvin W. Roberts, M.D., to the newly created position of Chief Medical Officer (CMO).
Bausch + Lomb, the global eye health company, announced today that it is activating a relief support plan in response to the earthquake and tsunami disaster affecting Japan.
Stephanie Haenchen Sr. Marketing Coordinator, Surgical Instruments +1-636-226-3788 or email@example.com
Bausch + Lomb Instruments for Ophthalmology, Ear, Nose, Throat and Plastic Surgery announced the launch of the Putterman Consecutive Conjunctivodacryocystorhinostomy Set in the United States.
The Pediatric Cataract Initiative has announced its inaugural small research grant recipients for treating and preventing vision loss in children.
Dr. Scott Lambert, a professor of ophthalmology at Emory University and a member of the advisory council for the Pediatric Cataract Initiative, offers parents tips to help protect kids’ eyes during spring activities.
Bausch + Lomb Announces Global Licensing Agreement with UltraVision CLPL to Market KeraSoft® Contact LensesJanuary 31, 2011 4:21 am | by Bausch + Lomb | News | Comments
Bausch + Lomb announced today a global licensing agreement with U.K.-based UltraVision CLPL to market and sell KeraSoft® soft contact lenses throughout the world, through the network of Bausch + Lomb lab channel partners.
Bausch + Lomb Manufacturing Sites in Florida Achieve Globally Recognized Certifications for Environment, Health, and Safety ManagementJanuary 26, 2011 8:22 am | by Bausch + Lomb | News | Comments
Bausch + Lomb announced today that it has secured two globally recognized certifications at its Tampa, Fla., and Clearwater, Fla., manufacturing sites.
In a recent global study to determine the hierarchy of vision-corrected patient needs, seeing better was the most important consideration for selecting eye care products.
Bausch + Lomb Storz® Ophthalmics Introduces Additions to its Single-Use Vitreoretinal Instruments LineJanuary 24, 2011 7:20 am | by Bausch + Lomb | News | Comments
Bausch + Lomb Storz® Ophthalmic Instruments is launching several new products to expand its line of single-use vitreoretinal instrumentation in the United States.
Bausch + Lomb, the global eye health company, announced today that it is offering a free iPhone application, called Crystalens® iClear, that will educate and entertain consumers about vision, cataracts and the B+L Crystalens product.
Voluntary Recall of Soothe® Xtra Hydration (XH) Eye Drops
Bausch + Lomb Appoints Rick Heinick as Corporate Vice President, Global Human Resources and TransformationDecember 21, 2010 8:21 am | by Bausch + Lomb | News | Comments
Bausch + Lomb, the global eye health company, has named Rick Heinick as corporate vice president, Global Human Resources and Transformation, effective January 4, 2011.
Bausch + Lomb, the global eye health company, announced today that it will extend its "See Better and Save" patient rebate program for patients who have the Crystalens® accommodating intraocular lens (IOL) implanted before March 31, 2011.
Bausch + Lomb Storz® Ophthalmic Instruments has launched a new line of single-use cataract instrumentation in the United States.
- Page 1